South African Biotech Startup Immobazyme Secures R25m in Growth Funding to Advance Local Biopharma Production
Tech In Africa - Dec 01, 2025
Immobazyme secured R25m ($1.45m) in growth funding, raising total capital to R50m ($2.9m). The funding round was led by the University Technology Fund with participation from University of Stellenbosch Enterprises and Fireball Capital.